Finally, the percentages of CD158a, CD158b, and CD158e1 were similar among the AML and control groups (Figures 5A–C), while the CD159a positive hypermature NK cells were clearly better represented in the control group (p = 0.001; Figure 5D). The gene discussed is KIR2DL3; the disease is acute myeloid leukemia.